Vaccines for COVID-19: How Protective Are They? When Will They Be Ready? A Leading Vaccinologist at Mount Sinai Weighs In | Mount Sinai Today

As the SARS-CoV-2 virus circulates throughout the world unchecked, researchers are racing to develop more than 135 vaccines. How well will these vaccines work and how soon will we be able to benefit from them?

In this article, leading SARS-CoV-2 antibody researcher, Florian Krammer, PhD, sheds light on vaccine research and how soon we will be able to benefit from them. Dr. Krammer details that there are currently more than 20 candidates in clinical development, five of which are located in the United States. While he feels good about encouraging results from phase 1 and 2 trials, he notes that phase 3 results are the most important and indicative of efficacy and safety of the vaccine as a whole. According to Dr. Krammer, if you don’t see efficacy, you don’t go forward. He concludes the interview by highlighting the potential complications of rolling out an effective vaccine.